While we were unable to find a suitable data set for male-specific disease like prostate cancer, the prognoscan database44 suggests that YBX1 expression increases hazard ratio in prostate cancer survival, and future work is needed to elucidate why this might be the case. Here, YBX1 is linked to prostate carcinoma.